The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

Gilead has returned the rights to a cancer candidate it licensed from Arcus Biosciences in a $725 million, multiprogram deal, ...

From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.

Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells ...

Cancer Antibody Drug Conjugates Market, Drugs Approval, Price, Sales & Clinical Trials Insight to 2030 - ResearchAndMarkets.com November 06, 2024 12:46 PM Eastern Standard Time ...

BARCELONA, Spain — Antibody-drug conjugates (ADCs) could address significant challenges in ovarian cancer treatment, as highlighted in a session at the European Society for Medical Oncology ...

Drs Ursula A. Matulonis and Leif W. Ellisen discuss endometrial cancer and ADCs, including resistance mechanisms, ADC sequencing, what's exciting in the field, and novel payloads.

News Dallas scientists developing light-activated treatment for late-stage stomach cancer Antibody-like molecules called betabodies might be the key to treating peritoneal carcinomatosis.